Abstract
HomeRadiologyVol. 250, No. 3 PreviousNext CommunicationsLetters to the EditorGadolinium-based Contrast Agents and Nephrogenic Systemic FibrosisRichard A. VittiRichard A. VittiAuthor AffiliationsMedical and Professional Services, GE Healthcare, 101 Carnegie Center, Princeton, NJ 08540 e-mail: [email protected]Richard A. VittiPublished Online:Mar 1 2009https://doi.org/10.1148/radiol.2503081497MoreSectionsFull textPDF ToolsImage ViewerAdd to favoritesCiteTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinked In References1 Wertman R, Altun E, Martin DR, et al. Risk of nephrogenic systemic fibrosis: evaluation of gadolinium chelate contrast agents at four American universities. Radiology 2008; 248(3): 799–806. Link, Google Scholar2 American College of Radiology. Manual on contrast media: version 6—2008 [book online]. Reston, Va: American College of Radiology, 2008. http://www.acr.org/SecondaryMainMenuCategories/quality_safety/contrast_manual.aspx. Updated October 6, 2008. Accessed December 10, 2008. Google ScholarArticle HistoryPublished in print: 2009 FiguresReferencesRelatedDetailsCited ByJournal of Computational Science, Vol. 58Inorganic Chemistry, Vol. 59, No. 10Journal of Magnetic Resonance Imaging, Vol. 42, No. 3European Journal of Radiology, Vol. 81, No. 10Journal of Computer Assisted Tomography, Vol. 36, No. 6Magnetic Resonance Imaging, Vol. 28, No. 2Pharmacoepidemiology and Drug Safety, Vol. 18, No. 11Recommended Articles Use of Intravenous Gadolinium-based Contrast Media in Patients with Kidney Disease and the Risk of Nephrogenic Systemic Fibrosis: Radiology In TrainingRadiology2021Volume: 300Issue: 2pp. 279-284A Systematic Review of 639 Patients with Biopsy-confirmed Nephrogenic Systemic FibrosisRadiology2019Volume: 292Issue: 2pp. 376-386Notice of Withdrawal: No Incidence of Nephrogenic Systemic Fibrosis after Gadobenate Dimeglumine Administration in Patients Undergoing Dialysis or Those with Severe Chronic Kidney DiseaseRadiology2010Volume: 286Issue: 1Gadolinium Retention and Deposition Revisited: How the Chemical Properties of Gadolinium-based Contrast Agents and the Use of Animal Models Inform Us about the Behavior of These Agents in the Human BrainRadiology2017Volume: 285Issue: 3pp. 721-724Gadolinium Deposition and Nephrogenic Systemic Fibrosis: A Radiologist’s PrimerRadioGraphics2019Volume: 40Issue: 1pp. 153-162See More RSNA Education Exhibits Gadolinium Deposition and NSF: Should I Be Worried?Digital Posters2018Gadolinium Deposition in Brain: An Updated ReviewDigital Posters2019Practical Approaches and Updated Topics in Gadoxetate-Enhanced MR Imaging of the Liver: What the Radiologists Should KnowDigital Posters2019 RSNA Case Collection Circumcaval ureter RSNA Case Collection2021Pulmonary manifestations of cystic fibrosisRSNA Case Collection2020Milk of Calcium Pericardial EffusionRSNA Case Collection2021 Vol. 250, No. 3 Metrics Altmetric Score PDF download
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
